Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company dedicated to improving health by developing, manufacturing, and marketing a broad range of high-quality, affordable medicines. With a primary focus on the Middle East and North Africa (MENA), the United States, and Europe, Hikma's portfolio includes injectables, generics, and branded pharmaceuticals across various therapeutic areas. The company strives to make essential medicines more accessible to patients worldwide, emphasizing quality, safety, and innovation in its operations.
Serves as the central hub for global strategy, corporate governance, finance, investor relations, and overarching management of Hikma's worldwide operations.
Located in Mayfair, a prestigious London district, suggesting a focus on global business and finance. The office itself is likely a modern, professional space within a commercial building, designed for corporate functions.
Likely professional, results-oriented, with an emphasis on global collaboration, ethical practices, and innovation in pharmaceuticals. Corporate functions would foster strategic thinking, international coordination, and adherence to high standards of governance.
Central point for strategic decision-making, financial oversight, and investor communications that guide Hikma's global operations, market expansion, and partnerships. Its London location provides access to international finance, talent, and a key regulatory environment.
Hikma Pharmaceuticals maintains a significant global presence with functions supported worldwide. This includes research and development (R&D) for new drug formulations and generics; state-of-the-art manufacturing facilities for injectables, oral solids, and other dosage forms in the US, Europe, and MENA; comprehensive quality assurance and control systems; regulatory affairs teams managing submissions across numerous international bodies; a robust global supply chain and logistics network; and tailored sales and marketing operations addressing the diverse needs of markets in the United States, Europe, and the Middle East & North Africa (MENA) region.
13 Hanover Square
London
N/A
United Kingdom
Address: 200 Connell Drive, Suite 5000, Berkeley Heights, NJ 07922, USA
To effectively navigate and lead Hikma's presence in the complex US pharmaceutical market, ensuring compliance with FDA regulations, and driving growth strategies tailored to American healthcare needs and demands.
Address: P.O. Box 182400, Amman 11118, Jordan (Bayader Wadi El-Seer)
Serves as a foundational site for Hikma's operations in the MENA region, leveraging local expertise and infrastructure to supply essential medicines and drive growth in these markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Hikma Pharmaceuticals' leadership includes:
Hikma Pharmaceuticals has been backed by several prominent investors over the years, including:
Over the past 12-18 months, Hikma Pharmaceuticals has seen significant leadership transitions, including the appointment of a new CEO through internal promotion, the confirmation of its CFO, and the departure of the previous CEO. These changes reflect a strategic evolution at the top of the company.
Discover the tools Hikma Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Hikma Pharmaceuticals commonly uses a standardized email format for its employees globally. The most prevalent pattern appears to be the first initial followed by the last name.
[first_initial][last]@hikma.com
Format
jsmith@hikma.com
Example
85%
Success rate
Hikma Pharmaceuticals PLC • March 7, 2024
Hikma announced robust financial results for the full year 2023, demonstrating significant revenue growth and strong profitability. The performance was driven by excellent results in its Injectables and Branded businesses, alongside a solid contribution from Generics....more
Hikma Pharmaceuticals PLC • February 20, 2024
Hikma announced the launch of Phenylephrine Hydrochloride Injection, USP, 10mg/mL, through its US affiliate. This launch expands their growing portfolio of essential injectable medicines for the US market, reinforcing their commitment to supplying critical hospital products....more
Hikma Pharmaceuticals PLC • November 9, 2023
Hikma provided a positive trading update, highlighting strong performance across its three core businesses and raising its full-year guidance for 2023. The update reflected continued operational momentum and successful strategic execution....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Hikma Pharmaceuticals, are just a search away.